Skip to main content
. 2024 Sep 4;6(3):499–516. doi: 10.3390/clockssleep6030033

Table 1.

Subject’s body composition before and after the 2-week DAZZEON αSleep® intervention.

Body Composition Pre Post ANOVA
Placebo αSleep® Placebo αSleep® Group Time G × T
SpO2 (%) 97.6 ± 0.9 a 96.8 ± 1.5 a 97.3 ± 1.1 a 96.8 ± 1.2 a F(1, 22) = 2.559
p = 0.124
F(1, 22) = 0.198
p = 0.660
F(1, 22) = 0.551
p = 0.466
Body weight (kg) 72.2 ± 5.6 a 77.7 ± 9.4 a 71.8 ± 5.5 a 77.7 ± 9.2 a F(1, 22) = 3.361
p = 0.080
F(1, 22) = 1.985
p = 0.173
F(1, 22) = 2.593
p = 0.122
BMI (kg/m2) 24.7 ± 1.7 a 26.0 ± 3.3 a 24.6 ± 1.6 a 26.0 ± 3.2 a F(1, 22) = 1.590
p = 0.221
F(1, 22) = 1.827
p = 0.190
F(1, 22) = 3.020
p = 0.096
Muscle mass (kg) 30.8 ± 3.6 a 32.5 ± 3.0 a 30.7 ± 3.5 a 32.5 ± 2.9 a F(1, 22) = 1.691
p = 0.207
F(1, 22) = 0.125
p = 0.727
F(1, 22) = 0.499
p = 0.488
Fat mass (%) 23.6 ± 5.7 a 25.1 ± 5.6 a 23.4 ± 5.4 a 25.2 ± 5.4 a F(1, 22) = 0.546
p = 0.468
F(1, 22) = 0.071
p = 0.792
F(1, 22) = 0.409
p = 0.529

Data are presented as mean ± SD. The same superscript letters (a) indicate no significant difference among groups at the same time point.